SCHEMBL6162920

SCHEMBL6162920

CCOC(=O)C(Cc1ccccc1)NC(=O)c1cc2cc(Cl)ccc2[nH]1

nearest known ligand 0.85

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
PYGL P06737 15/20 0.85
EGFR P00533 1/20 0.66
PTGS2 P35354 1/20 0.65
CYP51A1 Q16850 2/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6161267 0.92 PYGL (1.00) PYGLEGFRCYP51A1
SCHEMBL14587604 0.92 PYGL (1.00) PYGLEGFRCYP51A1
SCHEMBL6162901 0.91 PYGL (0.83) PYGLEGFRCYP51A1
SCHEMBL6162905 0.91 PYGL (0.83) PYGLEGFRCYP51A1
SCHEMBL6162503 0.87 PYGL (1.00) PYGLEGFRCYP51A1
Phenylalanine Methyl Ester SCHEMBL9051782 0.85 PYGL (0.87) PYGLEGFRCYP51A1
SCHEMBL2105859 0.85 PYGL (0.62) PYGLEGFRPTGS2CYP51A1
SCHEMBL2105855 0.85 PYGL (0.62) PYGLEGFRPTGS2CYP51A1
SCHEMBL29360910 0.85 PYGL (0.88) PYGLEGFRCYP51A1
SCHEMBL6339472 0.84 PYGL (0.81) PYGLEGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1134213-B1 Process for the preparation of substituted N-(indole-2-carbonyl)- glycinamides PFIZER (US) 2005-11-02 EP disclosed
EP-1134213-A2 Process for the preparation of substituted N-(indole-2-carbonyl)- glycinamides PFIZER INC. (US) 2001-09-19 EP disclosed
US-6277877-B1 GLYCOGEN PHOSPHORYLASE INHIBITOR; ANTIDIABETIC AGENTS PFIZER, INC. 2001-08-21 US disclosed
US-6107329-A HYPOTENSIVE AGENTS; CARDIOVASCULAR DISORDERS PFIZER, INC. (US) 2000-08-22 US disclosed
WO-1996039384-A1 SUBSTITUTED N-(INDOLE-2-CARBONYL)-GLYCINAMIDES AND DERIVATIVES AS GLYCOGEN PHOSPHORYLASE INHIBITORS PFIZER, INC. (US) 1996-12-12 WO disclosed